APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Selected research

Market Outlook & Growth Opportunities

Global Insulin Market Outlook and Growth Opportunities 2026

2 January 2026199 pages

Choose your research edition.

Industry ResearchInsulin Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

The major players in China Insulin market include Novo Nordisk, Eli Lilly, etc. The top 2 players occupy about 60% shares of the whole market. Tianjin and Jiangsu are main markets, they occupy about 60% of the whole market. Regular Human Insulin is the main type, with a share over 60%. Long Acting and Intermediate Acting are the main applications, which holds a share about 70%.

This report provides an overview of the global Insulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Insulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Insulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Insulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Insulin Segment by Company

Novo Nordisk

Eli Lilly

Sanofi-Aventis

Tonghua Dongbao

Ganlee

United Laboratory

Jiangsu Wanbang

Insulin Segment by Type

Animal Insulin

Regular Human Insulin

Insulin Analogue

Insulin Segment by Application

Short Acting

Intermediate Acting

Long Acting

Pre-Mix Insulin

Insulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Insulin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Insulin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Insulin significant trends, drivers, influence factors in global and regions.

6. To analyze Insulin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Insulin industry.

Chapter 3: Detailed analysis of Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Insulin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Insulin Industry Trends Table 2. Insulin Industry Drivers Table 3. Insulin Industry Opportunities and Challenges Table 4. Insulin Industry Restraints Table 5. Global Insulin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Insulin Revenue Share by Company (2021-2026) Table 7. Global Insulin Sales Volume by Company (M Pcs) & (2021-2026) Table 8. Global Insulin Sales Volume Share by Company (2021-2026) Table 9. Global Insulin Average Price (US$/Pcs) of Company (2021-2026) Table 10. Global Insulin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Insulin Key Company Manufacturing Base & Headquarters Table 12. Global Insulin Company, Product Type & Application Table 13. Global Insulin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Animal Insulin Table 18. Significant Companies of Regular Human Insulin Table 19. Significant Companies of Insulin Analogue Table 20. Global Insulin Sales Volume by Type 2021 VS 2025 VS 2032 (M Pcs) Table 21. Global Insulin Sales Volume by Type (2021-2026) & (M Pcs) Table 22. Global Insulin Sales Volume by Type (2027-2032) & (M Pcs) Table 23. Global Insulin Sales Volume Share by Type (2021-2026) Table 24. Global Insulin Sales Volume Share by Type (2027-2032) Table 25. Global Insulin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Insulin Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Insulin Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Insulin Sales Value Share by Type (2021-2026) Table 29. Global Insulin Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Short Acting Table 31. Significant Companies of Intermediate Acting Table 32. Significant Companies of Long Acting Table 33. Significant Companies of Pre-Mix Insulin Table 34. Global Insulin Sales Volume by Application 2021 VS 2025 VS 2032 (M Pcs) Table 35. Global Insulin Sales Volume by Application (2021-2026) & (M Pcs) Table 36. Global Insulin Sales Volume by Application (2027-2032) & (M Pcs) Table 37. Global Insulin Sales Volume Share by Application (2021-2026) Table 38. Global Insulin Sales Volume Share by Application (2027-2032) Table 39. Global Insulin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Insulin Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Insulin Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Insulin Sales Value Share by Application (2021-2026) Table 43. Global Insulin Sales Value Share by Application (2027-2032) Table 44. Global Insulin Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Table 45. Global Insulin Sales by Region (2021-2026) & (M Pcs) Table 46. Global Insulin Sales Market Share by Region (2021-2026) Table 47. Global Insulin Sales by Region (2027-2032) & (M Pcs) Table 48. Global Insulin Sales Market Share by Region (2027-2032) Table 49. Global Insulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Insulin Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Insulin Sales Value Share by Region (2021-2026) Table 52. Global Insulin Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Insulin Sales Value Share by Region (2027-2032) Table 54. Global Insulin Market Average Price (US$/Pcs) by Region (2021-2026) Table 55. Global Insulin Market Average Price (US$/Pcs) by Region (2027-2032) Table 56. Global Insulin Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 57. Global Insulin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Insulin Sales by Country (2021-2026) & (M Pcs) Table 59. Global Insulin Sales Market Share by Country (2021-2026) Table 60. Global Insulin Sales by Country (2027-2032) & (M Pcs) Table 61. Global Insulin Sales Market Share by Country (2027-2032) Table 62. Global Insulin Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Insulin Sales Value Market Share by Country (2021-2026) Table 64. Global Insulin Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Insulin Sales Value Market Share by Country (2027-2032) Table 66. Novo Nordisk Company Information Table 67. Novo Nordisk Business Overview Table 68. Novo Nordisk Insulin Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 69. Novo Nordisk Insulin Product Portfolio Table 70. Novo Nordisk Recent Development Table 71. Eli Lilly Company Information Table 72. Eli Lilly Business Overview Table 73. Eli Lilly Insulin Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 74. Eli Lilly Insulin Product Portfolio Table 75. Eli Lilly Recent Development Table 76. Sanofi-Aventis Company Information Table 77. Sanofi-Aventis Business Overview Table 78. Sanofi-Aventis Insulin Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 79. Sanofi-Aventis Insulin Product Portfolio Table 80. Sanofi-Aventis Recent Development Table 81. Tonghua Dongbao Company Information Table 82. Tonghua Dongbao Business Overview Table 83. Tonghua Dongbao Insulin Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 84. Tonghua Dongbao Insulin Product Portfolio Table 85. Tonghua Dongbao Recent Development Table 86. Ganlee Company Information Table 87. Ganlee Business Overview Table 88. Ganlee Insulin Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 89. Ganlee Insulin Product Portfolio Table 90. Ganlee Recent Development Table 91. United Laboratory Company Information Table 92. United Laboratory Business Overview Table 93. United Laboratory Insulin Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 94. United Laboratory Insulin Product Portfolio Table 95. United Laboratory Recent Development Table 96. Jiangsu Wanbang Company Information Table 97. Jiangsu Wanbang Business Overview Table 98. Jiangsu Wanbang Insulin Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 99. Jiangsu Wanbang Insulin Product Portfolio Table 100. Jiangsu Wanbang Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Insulin Distributors List Table 104. Insulin Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Insulin Product Image Figure 2. Global Insulin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Insulin Sales (2021-2032) & (M Pcs) Figure 5. Global Insulin Sales Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Insulin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Animal Insulin Image Figure 10. Regular Human Insulin Image Figure 11. Insulin Analogue Image Figure 12. Global Insulin Sales Volume by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 13. Global Insulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Insulin Sales Volume Share by Type (2021-2032) Figure 15. Global Insulin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Insulin Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Insulin Sales Value Share by Type (2021-2032) Figure 18. Short Acting Image Figure 19. Intermediate Acting Image Figure 20. Long Acting Image Figure 21. Pre-Mix Insulin Image Figure 22. Global Insulin Sales Volume by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 23. Global Insulin Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Insulin Sales Volume Share by Application (2021-2032) Figure 25. Global Insulin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Insulin Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Insulin Sales Value Share by Application (2021-2032) Figure 28. Global Insulin Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Figure 29. Global Insulin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Insulin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Insulin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Insulin Sales Value (2021-2032) & (US$ Million) Figure 33. North America Insulin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Insulin Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Insulin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Insulin Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Insulin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Insulin Sales Value (2021-2032) & (US$ Million) Figure 39. South America Insulin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Insulin Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Insulin Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Insulin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Insulin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Insulin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Insulin Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Insulin Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Animal Insulin
  • Regular Human Insulin
  • Insulin Analogue
Applications
  • Short Acting
  • Intermediate Acting
  • Long Acting
  • Pre-Mix Insulin
Companies covered
  • Novo Nordisk
  • Eli Lilly
  • Sanofi-Aventis
  • Tonghua Dongbao
  • Ganlee
  • United Laboratory
  • Jiangsu Wanbang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Sales Value (2021-2032)
  4. 1.2.2 Global Insulin Sales Volume (2021-2032)
  5. 1.2.3 Global Insulin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Insulin Market Dynamics
  1. 2.1 Insulin Industry Trends
  2. 2.2 Insulin Industry Drivers
  3. 2.3 Insulin Industry Opportunities and Challenges
  4. 2.4 Insulin Industry Restraints
3 Insulin Market by Company
  1. 3.1 Global Insulin Company Revenue Ranking in 2025
  2. 3.2 Global Insulin Revenue by Company (2021-2026)
  3. 3.3 Global Insulin Sales Volume by Company (2021-2026)
  4. 3.4 Global Insulin Average Price by Company (2021-2026)
  5. 3.5 Global Insulin Company Ranking (2024-2026)
  6. 3.6 Global Insulin Company Manufacturing Base and Headquarters
  7. 3.7 Global Insulin Company Product Type and Application
  8. 3.8 Global Insulin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Insulin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Insulin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Insulin Market by Type
  1. 4.1 Insulin Type Introduction
  2. 4.1.1 Animal Insulin
  3. 4.1.2 Regular Human Insulin
  4. 4.1.3 Insulin Analogue
  5. 4.2 Global Insulin Sales Volume by Type
  6. 4.2.1 Global Insulin Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Insulin Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Insulin Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Insulin Sales Value by Type
  10. 4.3.1 Global Insulin Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Insulin Sales Value by Type (2021-2032)
  12. 4.3.3 Global Insulin Sales Value Share by Type (2021-2032)
5 Insulin Market by Application
  1. 5.1 Insulin Application Introduction
  2. 5.1.1 Short Acting
  3. 5.1.2 Intermediate Acting
  4. 5.1.3 Long Acting
  5. 5.1.4 Pre-Mix Insulin
  6. 5.2 Global Insulin Sales Volume by Application
  7. 5.2.1 Global Insulin Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Insulin Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Insulin Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Insulin Sales Value by Application
  11. 5.3.1 Global Insulin Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Insulin Sales Value by Application (2021-2032)
  13. 5.3.3 Global Insulin Sales Value Share by Application (2021-2032)
6 Insulin Regional Sales and Value Analysis
  1. 6.1 Global Insulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Insulin Sales by Region (2021-2032)
  3. 6.2.1 Global Insulin Sales by Region: 2021-2026
  4. 6.2.2 Global Insulin Sales by Region (2027-2032)
  5. 6.3 Global Insulin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Insulin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Insulin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Insulin Sales Value by Region (2027-2032)
  9. 6.5 Global Insulin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Insulin Sales Value (2021-2032)
  12. 6.6.2 North America Insulin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Insulin Sales Value (2021-2032)
  15. 6.7.2 Europe Insulin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Insulin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Insulin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Insulin Sales Value (2021-2032)
  21. 6.9.2 South America Insulin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Insulin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Insulin Sales Value Share by Country, 2025 VS 2032
7 Insulin Country-level Sales and Value Analysis
  1. 7.1 Global Insulin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Insulin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Insulin Sales by Country (2021-2032)
  4. 7.3.1 Global Insulin Sales by Country (2021-2026)
  5. 7.3.2 Global Insulin Sales by Country (2027-2032)
  6. 7.4 Global Insulin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Insulin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Insulin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Insulin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Insulin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Insulin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Insulin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Insulin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Insulin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Insulin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Insulin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Insulin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Insulin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Insulin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Insulin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Insulin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Insulin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Insulin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Insulin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Insulin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Insulin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Insulin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Insulin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Insulin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Insulin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Insulin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Insulin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Insulin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Insulin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Insulin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Insulin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Insulin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Insulin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Insulin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Insulin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Insulin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Insulin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Insulin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Insulin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Insulin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Insulin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Insulin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Insulin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Insulin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Insulin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Insulin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Insulin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Insulin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Insulin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Insulin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Insulin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Insulin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Insulin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Insulin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Insulin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Insulin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Insulin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Insulin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Insulin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Insulin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Insulin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Insulin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Insulin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Insulin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Insulin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Insulin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Insulin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Insulin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Insulin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Insulin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Insulin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Insulin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Insulin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Insulin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Insulin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Insulin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Insulin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Insulin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Insulin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Insulin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Insulin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Insulin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Insulin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Insulin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Insulin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Insulin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Insulin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk
  2. 8.1.1 Novo Nordisk Company Information
  3. 8.1.2 Novo Nordisk Business Overview
  4. 8.1.3 Novo Nordisk Insulin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk Insulin Product Portfolio
  6. 8.1.5 Novo Nordisk Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Insulin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Insulin Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Sanofi-Aventis
  14. 8.3.1 Sanofi-Aventis Company Information
  15. 8.3.2 Sanofi-Aventis Business Overview
  16. 8.3.3 Sanofi-Aventis Insulin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi-Aventis Insulin Product Portfolio
  18. 8.3.5 Sanofi-Aventis Recent Developments
  19. 8.4 Tonghua Dongbao
  20. 8.4.1 Tonghua Dongbao Company Information
  21. 8.4.2 Tonghua Dongbao Business Overview
  22. 8.4.3 Tonghua Dongbao Insulin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tonghua Dongbao Insulin Product Portfolio
  24. 8.4.5 Tonghua Dongbao Recent Developments
  25. 8.5 Ganlee
  26. 8.5.1 Ganlee Company Information
  27. 8.5.2 Ganlee Business Overview
  28. 8.5.3 Ganlee Insulin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ganlee Insulin Product Portfolio
  30. 8.5.5 Ganlee Recent Developments
  31. 8.6 United Laboratory
  32. 8.6.1 United Laboratory Company Information
  33. 8.6.2 United Laboratory Business Overview
  34. 8.6.3 United Laboratory Insulin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 United Laboratory Insulin Product Portfolio
  36. 8.6.5 United Laboratory Recent Developments
  37. 8.7 Jiangsu Wanbang
  38. 8.7.1 Jiangsu Wanbang Company Information
  39. 8.7.2 Jiangsu Wanbang Business Overview
  40. 8.7.3 Jiangsu Wanbang Insulin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jiangsu Wanbang Insulin Product Portfolio
  42. 8.7.5 Jiangsu Wanbang Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Insulin Value Chain Analysis
  2. 9.1.1 Insulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Insulin Sales Mode & Process
  6. 9.2 Insulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Insulin Distributors
  9. 9.2.3 Insulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst